Cargando…

5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB

Detalles Bibliográficos
Autores principales: Kanter, J., Ataga, K., Bhasin, N., Guarino, S., Kutlar, A., Lanzkron, S., Manwani, D., McGann, P., Stowell, S., Tubman, V., Yermilov, I., Campos, C., Broder, M.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112637/
http://dx.doi.org/10.1097/01.HS9.0000928196.80128.ee
_version_ 1785027665512628224
author Kanter, J.
Ataga, K.
Bhasin, N.
Guarino, S.
Kutlar, A.
Lanzkron, S.
Manwani, D.
McGann, P.
Stowell, S.
Tubman, V.
Yermilov, I.
Campos, C.
Broder, M.S.
author_facet Kanter, J.
Ataga, K.
Bhasin, N.
Guarino, S.
Kutlar, A.
Lanzkron, S.
Manwani, D.
McGann, P.
Stowell, S.
Tubman, V.
Yermilov, I.
Campos, C.
Broder, M.S.
author_sort Kanter, J.
collection PubMed
description
format Online
Article
Text
id pubmed-10112637
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101126372023-04-19 5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB Kanter, J. Ataga, K. Bhasin, N. Guarino, S. Kutlar, A. Lanzkron, S. Manwani, D. McGann, P. Stowell, S. Tubman, V. Yermilov, I. Campos, C. Broder, M.S. Hemasphere Oral Presentations Lippincott Williams & Wilkins 2023-04-10 /pmc/articles/PMC10112637/ http://dx.doi.org/10.1097/01.HS9.0000928196.80128.ee Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Presentations
Kanter, J.
Ataga, K.
Bhasin, N.
Guarino, S.
Kutlar, A.
Lanzkron, S.
Manwani, D.
McGann, P.
Stowell, S.
Tubman, V.
Yermilov, I.
Campos, C.
Broder, M.S.
5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
title 5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
title_full 5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
title_fullStr 5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
title_full_unstemmed 5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
title_short 5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
title_sort 5613436 expert consensus on the management of infusion-related reactions (irrs) presenting with pain in patients receiving crizanlizumab
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112637/
http://dx.doi.org/10.1097/01.HS9.0000928196.80128.ee
work_keys_str_mv AT kanterj 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT atagak 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT bhasinn 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT guarinos 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT kutlara 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT lanzkrons 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT manwanid 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT mcgannp 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT stowells 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT tubmanv 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT yermilovi 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT camposc 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab
AT broderms 5613436expertconsensusonthemanagementofinfusionrelatedreactionsirrspresentingwithpaininpatientsreceivingcrizanlizumab